Medicud develops sustainable medical technologies focused on wound care, offering a single-use incisional negative pressure wound therapy (i‑NPWT) device. The device is designed to be easy to use, discreet, and reduces both therapy costs and ecological impact compared to traditional systems. Their patented solution targets suitable patients to improve healing outcomes while supporting environmentally responsible healthcare.
Funding
Funding not disclosed
Founders
Product
Problem
Incisional surgical wounds are susceptible to complications, including infection and dehiscence, which can increase healthcare costs and negatively impact patient recovery. Existing negative pressure wound therapy (NPWT) devices can be expensive, cumbersome, and ecologically taxing, hindering widespread adoption.
Solution
Medicud offers Dryum, a single-use, mechanically powered incisional NPWT device designed to promote safer wound healing while minimizing costs and environmental impact. This ultraportable solution delivers consistent negative pressure directly to the incisional site, reducing the risk of complications and improving overall healing outcomes. Dryum's ease of use and discreet design aim to make advanced wound care more accessible and sustainable for a broader range of patients. By providing an effective and affordable alternative to traditional NPWT, Medicud seeks to establish incisional negative pressure as the standard of care.
Target Audience
The primary target audience includes surgeons, hospitals, and wound care specialists seeking cost-effective and sustainable solutions for managing incisional surgical wounds.
Features
- Mechanically powered to deliver consistent negative pressure without electricity
- Single-use design to reduce the risk of cross-contamination and simplify disposal
- Ultraportable and discreet for enhanced patient comfort and mobility
- Easy-to-use application for simplified training and reduced setup time
- Sustainable design to minimize ecological footprint compared to conventional NPWT systems